1 ration, storiform fibrosis, and obliterative phlebitis.

2  cells, storiform fibrosis, and obliterative phlebitis.

3 ns were mainly lymphocytic periphlebitis and phlebitis.

4 cts and ductules, combined with obliterative phlebitis.

5 es, cardiac failure, bleeding diathesis, and phlebitis.

6  germinal centers, fibrosis and obliterative phlebitis.

7 tic central venous thrombosis was 0.054; arm phlebitis, 0.007; confirmed infection, 0.034; and cathet

8 ion (3.0%), leakage (1.5%), breakage (1.4%), phlebitis (1.2%), and thrombosis (0.5%).

9 ng is invasive and associated with a risk of phlebitis and thrombosis.

10 ve lesions, storiform fibrosis, obliterative phlebitis, and accumulation of IgG4-expressing plasma ce

11 asma cells, storiform fibrosis, obliterative phlebitis, and mild to moderate eosinophilia.

12 sma cells, tumefactive lesions, obliterative phlebitis, and mild to moderate eosinophilia.

13 te, superficial, white retinitis; arteritis; phlebitis; and retinal hemorrhages with or without macul

14 ous swelling, eosinophilia, and obliterative phlebitis are other frequently observed features.

15 is, occlusion, pain, infiltration, bleeding, phlebitis, catheter leakage and dislodgement) and whethe

16 ally mild, including (for caspofungin) local phlebitis, fever, abnormal liver function tests, and mil

17                                      Grade 2 phlebitis occurred in all patients before the use of cen

18                                           No phlebitis or symptomatic venous thrombosis occurred in a

19                                              Phlebitis or thrombophlebitis was more frequent in the p